These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28390068)

  • 1. Hostile takeover: how tumours hijack pre-existing vascular environments to thrive.
    Winkler F
    J Pathol; 2017 Jul; 242(3):267-272. PubMed ID: 28390068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.
    Denekamp J
    Br J Radiol; 1993 Mar; 66(783):181-96. PubMed ID: 7682469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are tumours angiogenesis-dependent?
    Verheul HM; Voest EE; Schlingemann RO
    J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
    Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
    J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progresses in cancer stem cell and its vascular microenvironment].
    Wang J; Deng L; Lu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Jun; 30(3):675-8. PubMed ID: 23865341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological features of vessel co-option versus sprouting angiogenesis.
    Latacz E; Caspani E; Barnhill R; Lugassy C; Verhoef C; Grünhagen D; Van Laere S; Fernández Moro C; Gerling M; Dirix M; Dirix LY; Vermeulen PB
    Angiogenesis; 2020 Feb; 23(1):43-54. PubMed ID: 31655928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour angiogenesis: the relevance to surgeons.
    Atkin GK; Chopada A
    Ann R Coll Surg Engl; 2006 Oct; 88(6):525-9. PubMed ID: 17059709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascular network of tumours--what is it not for?
    Sivridis E; Giatromanolaki A; Koukourakis MI
    J Pathol; 2003 Oct; 201(2):173-80. PubMed ID: 14517833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenesis in malignant tumours: Does it occur?
    Clarijs R; Ruiter DJ; de Waal RM
    J Pathol; 2001 Feb; 193(2):143-6. PubMed ID: 11180158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of angiogenesis in solid tumours: an overview.
    Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
    Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights into tumour metastasis: tracing the dominant events.
    Jin K; Li T; van Dam H; Zhou F; Zhang L
    J Pathol; 2017 Apr; 241(5):567-577. PubMed ID: 28035672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mathematical modelling of tumour angiogenesis and invasion.
    Chaplain MA
    Acta Biotheor; 1995 Dec; 43(4):387-402. PubMed ID: 8919350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Brief: Myeloid-derived suppressor cells in cancer.
    Solito S; Pinton L; Mandruzzato S
    J Pathol; 2017 May; 242(1):7-9. PubMed ID: 28097660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inhibitors of tumor angiogenesis].
    Mattot V; Vandenbunder B
    Bull Cancer; 1997 Apr; 84(4):447-50. PubMed ID: 9238174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the vascular component in growth of solid tumors: a historical review].
    Ribatti D; Vacca A
    Ann Ital Med Int; 1994; 9(2):92-5. PubMed ID: 7522501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vessel co-option in cancer.
    Kuczynski EA; Vermeulen PB; Pezzella F; Kerbel RS; Reynolds AR
    Nat Rev Clin Oncol; 2019 Aug; 16(8):469-493. PubMed ID: 30816337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration.
    Legg JA; Herbert JM; Clissold P; Bicknell R
    Angiogenesis; 2008; 11(1):13-21. PubMed ID: 18264786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
    Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
    J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.